المؤلفون: Karatkevich, D., Losmanova, T., Zens, P., Deng, H., Dubey, C., Zhang, T., Casty, C., Gao, Y., Neppl, C., Berezowska, S., Wang, W., Peng, R.W., Schmid, R.A., Dorn, P., Marti, T.M.

المصدر: Scientific reports, vol. 14, no. 1, pp. 18206

مصطلحات موضوعية: Humans, Capecitabine/pharmacology, Animals, Cell Line, Tumor, Mesothelioma, Malignant/drug therapy, Malignant/metabolism, Malignant/pathology, Cytidine Deaminase/metabolism, Cytidine Deaminase/genetics, Mice, Pemetrexed/pharmacology, Pleural Neoplasms/drug therapy, Pleural Neoplasms/metabolism, Pleural Neoplasms/pathology, Xenograft Model Antitumor Assays, Cisplatin/pharmacology, Cisplatin/therapeutic use, Lung Neoplasms/drug therapy, Lung Neoplasms/metabolism, Lung Neoplasms/pathology, Epithelial-Mesenchymal Transition/drug effects, Mesothelioma/drug therapy, Mesothelioma/metabolism, Mesothelioma/pathology, Female, Antineoplastic Combined Chemotherapy Protocols/pharmacology, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Gene Expression Regulation

وصف الملف: application/pdf

Relation: info:eu-repo/semantics/altIdentifier/pmid/39107509; info:eu-repo/semantics/altIdentifier/eissn/2045-2322; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_4EC8964DB10E1; https://serval.unil.ch/notice/serval:BIB_4EC8964DB10E; https://serval.unil.ch/resource/serval:BIB_4EC8964DB10E.P001/REF.pdf

الاتاحة: https://serval.unil.ch/notice/serval:BIB_4EC8964DB10E
https://doi.org/10.1038/s41598-024-69347-x
https://serval.unil.ch/resource/serval:BIB_4EC8964DB10E.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_4EC8964DB10E1

المساهمون: Ismail M Meraz, Mourad Majidi, RuPing Shao, Feng Meng, Min Jin Ha, Elizabeth Shpall, Jack A Roth, Ha, Min Jin

مصطلحات موضوعية: AMP-Activated Protein Kinases* / genetics, AMP-Activated Protein Kinases* / immunology, Animals, Antibodies, Monoclonal, Humanized / administration & dosage, Antineoplastic Combined Chemotherapy Protocols / pharmacology, Carboplatin / administration & dosage, Carcinoma, Non-Small-Cell Lung* / drug therapy, Non-Small-Cell Lung* / genetics, Non-Small-Cell Lung* / therapy, Disease Models, Animal, Genes, Tumor Suppressor, Lung Neoplasms* / drug therapy, Lung Neoplasms* / genetics, Lung Neoplasms* / therapy, Mice, Proto-Oncogene Proteins p21(ras)* / genetics, Proto-Oncogene Proteins p21(ras)* / immunology, Tumor Microenvironment, Tumor Suppressor Proteins* / genetics, Tumor Suppressor Proteins* / immunology

Relation: COMMUNICATIONS BIOLOGY; J03836; OAK-2022-02425; https://ir.ymlib.yonsei.ac.kr/handle/22282913/189285; T202202164; COMMUNICATIONS BIOLOGY, Vol.5(1) : 167, 2022-02

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/189285
https://doi.org/10.1038/s42003-022-03103-7

المؤلفون: Dutta, Rinku, Khalil, Roukiah, Mayilsamy, Karthick, Green, Ryan, Howell, Mark, Bharadwaj, Srinivas, Mohapatra, Shyam S., Mohapatra, Subhra

المصدر: Frontiers in immunology, 12:706133

مصطلحات موضوعية: Female [MeSH], Immunology, Mice, Inbred C57BL [MeSH], PD-L1, colorectal cancer, Mithramycin-A, Plicamycin/analogs, Animals [MeSH], Mice [MeSH], Antineoplastic Combined Chemotherapy Protocols/pharmacology [MeSH], Colorectal Neoplasms/pathology [MeSH], combination therapy, Colorectal Neoplasms/immunology [MeSH], Disease Models, Animal [MeSH], Immune Checkpoint Inhibitors/pharmacology [MeSH], Plicamycin/pharmacology [MeSH], orthotopic tumor

Relation: https://repository.publisso.de/resource/frl:6478172; https://doi.org/10.3389/fimmu.2021.706133; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350740/

الاتاحة: https://repository.publisso.de/resource/frl:6478172
https://doi.org/10.3389/fimmu.2021.706133
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350740/

المؤلفون: Meyer, Felix B., Goebel, Sophie, Spangel, Sonja B., Leovsky, Christiane, Hoelzer, Doerte, Thierbach, René

المصدر: http://lobid.org/resources/99370673697106441#!, 21(1):629.

مصطلحات موضوعية: Energy metabolism, BALB 3T3 Cells [MeSH], Cancer, Mitomycin/pharmacology [MeSH], Metformin/therapeutic use [MeSH], Doxorubicin/pharmacology [MeSH], Culture Media/metabolism [MeSH], Drug Interactions [MeSH], In vitro model, Glucose/metabolism [MeSH], Fluorouracil/pharmacology [MeSH], Cell Transformation, Neoplastic/chemically induced [MeSH], Docetaxel/pharmacology [MeSH], Drug Evaluation, Preclinical [MeSH], Fluorouracil/therapeutic use [MeSH], Humans [MeSH], Metformin, Carcinogens/toxicity [MeSH], Cell Survival/drug effects [MeSH], Animals [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Docetaxel/therapeutic use [MeSH], Methylcholanthrene/toxicity [MeSH], Mice [MeSH], Antineoplastic Combined Chemotherapy Protocols/pharmacology [MeSH], Adjuvant, Neoplasms/drug therapy [MeSH], Research

Relation: https://repository.publisso.de/resource/frl:6462827; https://doi.org/10.1186/s12885-021-08354-x; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161985/

الاتاحة: https://repository.publisso.de/resource/frl:6462827
https://doi.org/10.1186/s12885-021-08354-x
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161985/

المؤلفون: Grunenberg, Alexander, Kaiser, Lisa M., Woelfle, Stephanie, Schmelzle, Birgit, Viardot, Andreas, Möller, Peter, Barth, Thomas F. E., Muche, Rainer, Dreyhaupt, Jens, Raderer, Markus, Kiesewetter, Barbara, Buske, Christian

المصدر: http://lobid.org/resources/99370673697106441#!, 21(1):749.

مصطلحات موضوعية: Pyrimidines/pharmacology [MeSH], Antibodies, Monoclonal/therapeutic use [MeSH], Lymphoma, B-Cell, Marginal Zone/drug therapy [MeSH], Study Protocol, Humans [MeSH], Prospective Studies [MeSH], Monoclonal/pharmacology [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], PI3K inhibitor, Medical and radiation oncology, Pyrimidines/therapeutic use [MeSH], Copanlisib, Antineoplastic Combined Chemotherapy Protocols/pharmacology [MeSH], Marginal zone lymphoma, Quinazolines/pharmacology [MeSH], Phosphoinositide-3 Kinase Inhibitors/therapeutic use [MeSH], Quinazolines/therapeutic use [MeSH], Rituximab

Relation: https://repository.publisso.de/resource/frl:6462819; https://doi.org/10.1186/s12885-021-08464-6; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243426/

الاتاحة: https://repository.publisso.de/resource/frl:6462819
https://doi.org/10.1186/s12885-021-08464-6
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243426/

المؤلفون: Parczyk, Jonas, Ruhnau, Jérôme, Pelz, Carsten, Schilling, Max, Wu, Hao, Piaskowski, Nicole Nadine, Eickholt, Britta, Kühn, Hartmut, Danker, Kerstin, Klein, Andreas

المصدر: http://lobid.org/resources/99370673697106441#!, 21(1):481.

مصطلحات موضوعية: HIF-1α inhibition, Drug combination, Cell Line, Tumor/drug effects [MeSH], Drug Synergism [MeSH], Phenylpropionates/pharmacology [MeSH], Synergism, Experimental therapeutics and drug development, Drug Screening Assays, Antitumor/methods [MeSH], Dichloroacetic Acid/pharmacology [MeSH], MCF-7 Cells [MeSH], Dichloroacetate, Metabolism, Research Article, A549 Cells [MeSH], Dose-Response Relationship, Drug [MeSH], Cancer therapy, Humans [MeSH], Reactive Oxygen Species/metabolism [MeSH], Cell Cycle Checkpoints/drug effects [MeSH], Apoptosis/drug effects [MeSH], Cell Survival/drug effects [MeSH], HT29 Cells [MeSH], Cancer cell lines, Antineoplastic Combined Chemotherapy Protocols/pharmacology [MeSH], PX-478, Cell Proliferation/drug effects [MeSH], HeLa Cells [MeSH]

Relation: https://repository.publisso.de/resource/frl:6462811; https://doi.org/10.1186/s12885-021-08186-9; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086110/

الاتاحة: https://repository.publisso.de/resource/frl:6462811
https://doi.org/10.1186/s12885-021-08186-9
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086110/

المؤلفون: Vay, Christian, Schlünder, Philipp M., Dizdar, Levent, Esposito, Irene, Ghadimi, Markus P. H., Knoefel, Wolfram T., Krieg, Andreas

المصدر: http://lobid.org/resources/99370674181806441#!, 148(3):633-645.

مصطلحات موضوعية: Aged, 80 and over [MeSH], Liposarcoma, Aged [MeSH], Survivin/antagonists, Naphthoquinones/administration, Tumor Cells, Cultured [MeSH], Etoposide/administration, Male [MeSH], Doxorubicin/administration, Targeted therapy, Liposarcoma/drug therapy [MeSH], Liposarcoma/classification [MeSH], Liposarcoma/pathology [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Original Article – Cancer Research, Adult [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Apoptosis, Middle Aged [MeSH], Survivin, Gene Expression Regulation, Neoplastic/drug effects [MeSH], Survival Rate [MeSH], Antineoplastic Combined Chemotherapy Protocols/pharmacology [MeSH], Prognosis [MeSH], Liposarcoma/metabolism [MeSH]

Relation: https://repository.publisso.de/resource/frl:6446878; https://doi.org/10.1007/s00432-021-03871-5; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881260/

الاتاحة: https://repository.publisso.de/resource/frl:6446878
https://doi.org/10.1007/s00432-021-03871-5
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881260/

المساهمون: Yelena Y Janjigian, Akihito Kawazoe, Patricio Yañez, Ning Li, Sara Lonardi, Oleksii Kolesnik, Olga Barajas, Yuxian Bai, Lin Shen, Yong Tang, Lucjan S Wyrwicz, Jianming Xu, Kohei Shitara, Shukui Qin, Eric Van Cutsem, Josep Tabernero, Lie Li, Sukrut Shah, Pooja Bhagia, Hyun Cheol Chung, Chung, Hyun Cheol

مصطلحات موضوعية: Adenocarcinoma / drug therapy, Adenocarcinoma / pathology, Antibodies, Monoclonal, Humanized* / pharmacology, Humanized* / therapeutic use, Antineoplastic Combined Chemotherapy Protocols / pharmacology, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Esophagogastric Junction / drug effects, Esophagogastric Junction / pathology, Humans, Programmed Cell Death 1 Receptor* / antagonists & inhibitors, Receptor, ErbB-2* / antagonists & inhibitors, ErbB-2* / metabolism, Stomach Neoplasms* / drug therapy, Stomach Neoplasms* / metabolism, Stomach Neoplasms* / pathology, Trastuzumab* / pharmacology, Trastuzumab* / therapeutic use

Relation: NATURE; J02289; OAK-2022-05363; https://ir.ymlib.yonsei.ac.kr/handle/22282913/191111; T999202278; NATURE, Vol.600(7890) : 727-730, 2021-12

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/191111
https://doi.org/10.1038/s41586-021-04161-3

المساهمون: Jiyun Lee, Seock-Ah Im, Gun Min Kim, Kyung Hae Jung, Seok Yun Kang, In Hae Park, Jee Hyun Kim, Hee Kyung Ahn, Yeon Hee Park, Kim, Gun Min

مصطلحات موضوعية: Adult, Androstadienes / pharmacology, Androstadienes / therapeutic use, Antineoplastic Agents, Hormonal / pharmacology, Hormonal / therapeutic use, Antineoplastic Combined Chemotherapy Protocols / pharmacology, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Breast Neoplasms / mortality, Breast Neoplasms / pathology, Breast Neoplasms / therapy, Chemotherapy, Adjuvant / methods, Clinical Trials, Phase II as Topic, Female, Humans, Mastectomy, Middle Aged, Multicenter Studies as Topic, Neoplasm Recurrence, Local / mortality, Local / pathology, Local / therapy, Piperazines / pharmacology, Piperazines / therapeutic use, Progression-Free Survival, Protein Kinase Inhibitors / pharmacology, Protein Kinase Inhibitors / therapeutic use, Pyridines / pharmacology

Relation: CANCER RESEARCH AND TREATMENT; J00453; OAK-2022-04298; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190463; T202126091; CANCER RESEARCH AND TREATMENT, Vol.53(3) : 695-702, 2021-07

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/190463
https://doi.org/10.4143/crt.2020.1246

المساهمون: Hun Ho Park, Junseong Park, Hye Joung Cho, Jin-Kyoung Shim, Ju Hyung Moon, Eui Hyun Kim, Jong Hee Chang, Soo Youl Kim, Seok-Gu Kang, Kang, Seok Gu

مصطلحات موضوعية: Aldehyde Dehydrogenase / antagonists & inhibitors, Aldehyde Dehydrogenase / metabolism, Antineoplastic Combined Chemotherapy Protocols / pharmacology, Brain Neoplasms* / drug therapy, Brain Neoplasms* / enzymology, Electron Transport Complex I / antagonists & inhibitors, Electron Transport Complex I / metabolism, Enzyme Inhibitors / pharmacology, Glioblastoma* / drug therapy, Glioblastoma* / enzymology, Humans, Neoplasm Proteins / antagonists & inhibitors, Neoplasm Proteins / metabolism, Spheroids, Cellular / enzymology, Temozolomide / pharmacology, aldehyde dehydrogenase, bioenergenetics, glioblastoma, oxidative phosphorylation, temozolomide, tumorsphere

Relation: MOLECULES; J03201; OAK-2021-01361; https://ir.ymlib.yonsei.ac.kr/handle/22282913/182022; T202100210; MOLECULES, Vol.26(2) : 282, 2021-01

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/182022
https://doi.org/10.3390/molecules26020282

المؤلفون: Martinez Sanz, Paula, van Rees, Dieke J, van Zogchel, Lieke M J, Klein, Bart, Bouti, Panagiota, Olsman, Hugo, Schornagel, Karin, Kok, Ivana, Sunak, Ali, Leeuwenburg, Kira, Timmerman, Ilse, Dierselhuis, Miranda P, Kholosy, Waleed M, Molenaar, Jan J, van Bruggen, Robin, van den Berg, Timo K, Kuijpers, Taco W, Matlung, Hanke L, Tytgat, Godelieve A M, Franke, Katka

المساهمون: Afd Pharmaceutics, Pharmaceutics

مصطلحات موضوعية: Adjuvants, Immunologic/pharmacology, Antibodies, Monoclonal/pharmacology, Antineoplastic Agents, Immunological/pharmacology, Antineoplastic Combined Chemotherapy Protocols/pharmacology, CD11b Antigen/metabolism, CD18 Antigens/metabolism, Cell Line, Tumor, Cell Proliferation/drug effects, Coculture Techniques, Cytotoxicity, Immunologic/drug effects, Granulocyte Colony-Stimulating Factor/pharmacology, Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology, Humans, Neuroblastoma/drug therapy, Neutrophils/drug effects, Receptors, IgG/metabolism, Trogocytosis/drug effects, Tumor Microenvironment

وصف الملف: application/pdf

Relation: https://dspace.library.uu.nl/handle/1874/419438

الاتاحة: https://dspace.library.uu.nl/handle/1874/419438

المؤلفون: Hutchings, Martin, Radford, John, Ansell, Stephen M., Illés, Árpád, Sureda, Anna, Connors, Joseph M., Sýkorová, Alice, Shibayama, Hirohiko, Abramson, Jeremy S., Chua, Neil S., Friedberg, Jonathan W., Kořen, Jan, LaCasce, Ann Steward, Molina, Lysiane, Engley, Gerald, Fenton, Keenan, Jolin, Hina, Liu, Rachael, Gautam, Ashish, Gallamini, Andrea

المصدر: Hutchings , M , Radford , J , Ansell , S M , Illés , Á , Sureda , A , Connors , J M , Sýkorová , A , Shibayama , H , Abramson , J S , Chua , N S , Friedberg , J W , Kořen , J , LaCasce , A S , Molina , L , Engley , G , Fenton , K , Jolin , H , Liu , R , Gautam , A & Gallamini , A 2021 , ' Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, ....

مصطلحات موضوعية: Adult, Antineoplastic Combined Chemotherapy Protocols/pharmacology, Brentuximab Vedotin/pharmacology, Dacarbazine/pharmacology, Doxorubicin/pharmacology, Female, Hodgkin Disease/drug therapy, Humans, Male, Middle Aged, Neoplasm Staging/methods, Risk Factors, Vinblastine/pharmacology, ResearchInstitutes_Networks_Beacons/mcrc, Manchester Cancer Research Centre

الاتاحة: https://research.manchester.ac.uk/en/publications/b04d98f9-8c1f-4166-9ede-e5f06aab0011
https://doi.org/10.1002/hon.2838

المؤلفون: Zou, F., Faleck, D., Thomas, A., Harris, J., Satish, D., Wang, X., Charabaty, A., Ernstoff, M.S., Glitza Oliva, I.C., Hanauer, S., McQuade, J., Obeid, M., Shah, A., Richards, D.M., Sharon, E., Wolchok, J., Thompson, J., Wang, Y.

المصدر: Journal for immunotherapy of cancer, vol. 9, no. 11, pp. e003277

مصطلحات موضوعية: Antibodies, Monoclonal, Humanized/pharmacology, Humanized/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/pharmacology, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Colitis/drug therapy, Diarrhea/drug therapy, Female, Humans, Infliximab/pharmacology, Infliximab/therapeutic use, Male, Middle Aged, Neoplasms/complications, Neoplasms/drug therapy, Neoplasms/pathology, cytotoxicity, immunologic, immunotherapy, inflammation, melanoma

وصف الملف: application/pdf

Relation: info:eu-repo/semantics/altIdentifier/pmid/34789551; info:eu-repo/semantics/altIdentifier/eissn/2051-1426; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_D947D0B8BF9D0; https://serval.unil.ch/notice/serval:BIB_D947D0B8BF9D; https://serval.unil.ch/resource/serval:BIB_D947D0B8BF9D.P001/REF.pdf

الاتاحة: https://serval.unil.ch/notice/serval:BIB_D947D0B8BF9D
https://doi.org/10.1136/jitc-2021-003277
https://serval.unil.ch/resource/serval:BIB_D947D0B8BF9D.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_D947D0B8BF9D0

المؤلفون: Højholt, Karen Louise, Gregersen, Henrik, Szabo, Agoston Gyula, Klausen, Tobias Wirenfeldt, Levring, Mette Bøegh, Preiss, Birgitte, Helleberg, Carsten, Breinholt, Marie Fredslund, Hermansen, Emil, Rahbek Gjerdrum, Lise Mette, Bønløkke, Søren Thorgaard, Nielsen, Katrine, Kjeldsen, Eigil, Iversen, Katrine Fladeland, Teodorescu, Elena Manuela, Kurt, Eva, Strandholdt, Casper, Andersen, Mette Klarskov, Vangsted, Annette Juul

المصدر: Højholt , K L , Gregersen , H , Szabo , A G , Klausen , T W , Levring , M B , Preiss , B , Helleberg , C , Breinholt , M F , Hermansen , E , Rahbek Gjerdrum , L M , Bønløkke , S T , Nielsen , K , Kjeldsen , E , Iversen , K F , Teodorescu , E M , Kurt , E , Strandholdt , C , Andersen , M K & Vangsted , A J 2021 , ' Outcome of treatment with carfilzomib before and after treatment ....

مصطلحات موضوعية: carfilzomib, daratumumab, multiple myeloma, real-world evidence, Humans, Middle Aged, Neoplasm Recurrence, Local, Treatment Outcome, Antineoplastic Combined Chemotherapy Protocols/pharmacology, Oligopeptides/pharmacology, Aged, Retrospective Studies, Multiple Myeloma/drug therapy, Antibodies, Monoclonal/pharmacology

وصف الملف: application/pdf

Relation: https://portal.findresearcher.sdu.dk/da/publications/3205a743-e998-4521-9f10-c9df06ddd93b

الاتاحة: https://portal.findresearcher.sdu.dk/da/publications/3205a743-e998-4521-9f10-c9df06ddd93b
https://doi.org/10.1002/hon.2906
https://findresearcher.sdu.dk/ws/files/189845288/hon.2906.pdf

المؤلفون: Gupta, Siddharth, Pungsrinont, Thanakorn, Ženata, Ondrej, Neubert, Laura, Vrzal, Radim, Baniahmad, Aria

المصدر: http://lobid.org/resources/99370675590706441#!, 11(3-4):182-190.

مصطلحات موضوعية: Androgen Receptor Antagonists/therapeutic use [MeSH], Benzamides/pharmacology [MeSH], Interleukin-23/metabolism [MeSH], Nitriles/therapeutic use [MeSH], Nitriles/pharmacology [MeSH], Cellular Senescence [MeSH], Humans [MeSH], Pyrazoles/pharmacology [MeSH], Pyrazoles/therapeutic use [MeSH], Interleukin-23, Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Phenylthiohydantoin/pharmacology [MeSH], Androgen receptor antagonists, Cellular senescence, Male [MeSH], Antineoplastic Combined Chemotherapy Protocols/pharmacology [MeSH], Phenylthiohydantoin/therapeutic use [MeSH], Androgen Receptor Antagonists/pharmacology [MeSH], Prostate cancer spheroids, Benzamides/therapeutic use [MeSH], Original Paper

Relation: https://repository.publisso.de/resource/frl:6471922; https://doi.org/10.1007/s12672-020-00391-5; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335377/

الاتاحة: https://repository.publisso.de/resource/frl:6471922
https://doi.org/10.1007/s12672-020-00391-5
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335377/

المؤلفون: Kerschner-Morales, Sophie L., Kühne, Marie, Becker, Sabine, Beck, James F., Sonnemann, Jürgen

المصدر: http://lobid.org/resources/99370674181806441#!, 146(11):2871-2883.

مصطلحات موضوعية: Pyrimidines/pharmacology [MeSH], Centrinone, Cell Line, Tumor [MeSH], Membrane Potential, Mitochondrial/drug effects [MeSH], Original Article – Cancer Research, Humans [MeSH], Apoptosis/drug effects [MeSH], Indazoles/pharmacology [MeSH], Cell Survival/drug effects [MeSH], Apoptosis, Cell cycle, Polo-like kinase 4, Protein-Serine-Threonine Kinases/antagonists, Antineoplastic Combined Chemotherapy Protocols/pharmacology [MeSH], Indoles/pharmacology [MeSH], Sarcoma, Ewing/pathology [MeSH], Ewing’s sarcoma, CFI-400945, Bone Neoplasms/pathology [MeSH], Sulfones/pharmacology [MeSH]

Relation: https://repository.publisso.de/resource/frl:6469380; https://doi.org/10.1007/s00432-020-03346-z; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519924/

الاتاحة: https://repository.publisso.de/resource/frl:6469380
https://doi.org/10.1007/s00432-020-03346-z
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519924/

المؤلفون: Schummer, Patrick, Schilling, Bastian, Gesierich, Anja

المصدر: http://lobid.org/resources/99370677062806441#!, 21(4):493-504.

مصطلحات موضوعية: Proto-Oncogene Proteins B-raf/genetics [MeSH], Progression-Free Survival [MeSH], Gain of Function Mutation [MeSH], Skin Neoplasms/drug therapy [MeSH], Dermatology, Neoplasm Staging [MeSH], Melanoma/drug therapy [MeSH], Pharmacotherapy, Melanoma/diagnosis [MeSH], Proto-Oncogene Proteins B-raf/antagonists, Pharmacology/Toxicology, Melanoma/genetics [MeSH], Protein Kinase Inhibitors/pharmacology [MeSH], Humans [MeSH], Review Article, Melanoma/mortality [MeSH], Protein Kinase Inhibitors/therapeutic use [MeSH], Time Factors [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Immune Checkpoint Inhibitors/therapeutic use [MeSH], Survival Rate [MeSH], Mitogen-Activated Protein Kinase Kinases/antagonists, Skin Neoplasms/genetics [MeSH], Antineoplastic Combined Chemotherapy Protocols/pharmacology [MeSH], Skin Neoplasms/mortality [MeSH], Skin Neoplasms/diagnosis [MeSH], Immune Checkpoint Inhibitors/pharmacology [MeSH]

Relation: https://repository.publisso.de/resource/frl:6465103; https://doi.org/10.1007/s40257-020-00509-z; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371660/

الاتاحة: https://repository.publisso.de/resource/frl:6465103
https://doi.org/10.1007/s40257-020-00509-z
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371660/

المؤلفون: Ebert, Karolin, Zwingenberger, Gwen, Barbaria, Elena, Keller, Simone, Heck, Corinna, Arnold, Rouven, Hollerieth, Vanessa, Mattes, Julian, Geffers, Robert, Raimúndez, Elba, Hasenauer, Jan, Luber, Birgit

المصدر: http://lobid.org/resources/99370673697106441#!, 20(1):1039.

مصطلحات موضوعية: Cetuximab/administration, Phosphoproteins/metabolism [MeSH], Stomach Neoplasms/pathology [MeSH], Trastuzumab/administration, Afatinib/administration, Cell Movement [MeSH], Phosphoproteins/genetics [MeSH], Apoptosis [MeSH], Tumor Cells, Cultured [MeSH], Stomach Neoplasms/drug therapy [MeSH], Gene expression, Phenotype [MeSH], Cell and molecular biology, Research Article, Trastuzumab, Gastric cancer, Stomach Neoplasms/genetics [MeSH], Afatinib, Cell Proliferation [MeSH], Phosphoprotein, Humans [MeSH], Stomach Neoplasms/metabolism [MeSH], Gene Expression Regulation, Neoplastic/drug effects [MeSH], Antineoplastic Combined Chemotherapy Protocols/pharmacology [MeSH], Biomarkers, Tumor/metabolism [MeSH], Tumor/genetics [MeSH], Cetuximab

Relation: https://repository.publisso.de/resource/frl:6464617; https://doi.org/10.1186/s12885-020-07540-7; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594334/

الاتاحة: https://repository.publisso.de/resource/frl:6464617
https://doi.org/10.1186/s12885-020-07540-7
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594334/

المساهمون: Lillian M Smyth, Sarina A Piha-Paul, Helen H Won, Alison M Schram, Cristina Saura, Sherene Loi, Janice Lu, Geoffrey I Shapiro, Dejan Juric, Ingrid A Mayer, Carlos L Arteaga, Macarena I de la Fuente, Adam M Brufksy, Iben Spanggaard, Morten Mau-Sørensen, Monica Arnedos, Victor Moreno, Valentina Boni, Joohyuk Sohn, Lee S Schwartzberg, Xavier Gonzàlez-Farré, Andrés Cervantes, François-Clement Bidard, Alexander N Gorelick, Richard B Lanman, Rebecca J Nagy, Gary A Ulaner, Sarat Chandarlapaty, Komal Jhaveri, Elena I Gavrila, Catherine Zimel, S Duygu Selcuklu, Myra Melcer, Aliaksandra Samoila, Yanyan Cai, Maurizio Scaltriti, Grace Mann, Feng Xu, Lisa D Eli, Melanie Dujka, Alshad S Lalani, Richard Bryce, José Baselga, Barry S Taylor, David B Solit, Funda Meric-Bernstam, David M Hyman, Sohn, Joo Hyuk

مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols / pharmacology, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Breast Neoplasms / drug therapy, Breast Neoplasms / genetics, Breast Neoplasms / pathology, Breast Neoplasms, Male / drug therapy, Male / genetics, Male / pathology, Cell Line, Tumor, DNA Mutational Analysis, Drug Resistance, Neoplasm / drug effects, Neoplasm / genetics, Drug Synergism, Estrogen Receptor Antagonists / pharmacology, Estrogen Receptor Antagonists / therapeutic use, Female, Fulvestrant / pharmacology, Fulvestrant / therapeutic use, Humans, Male, Middle Aged, Mutation, Prospective Studies, Protein Kinase Inhibitors / pharmacology

Relation: CANCER DISCOVERY; J03328; OAK-2022-03914; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190231; T9992020456; CANCER DISCOVERY, Vol.10(2) : 198-213, 2020-02

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/190231
https://doi.org/10.1158/2159-8290.CD-19-0966

المساهمون: Ki Sun Jung, Kihyun Kim, Hyo Jung Kim, Sung Hyun Kim, Jeong-Ok Lee, Jin Seok Kim, Je-Jung Lee, Hyeon-Seok Eom, Chang-Ki Min, Ho-Jin Shin, Kim, Jin Seok

مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols / pharmacology, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Bortezomib / pharmacology, Bortezomib / therapeutic use, Dexamethasone / pharmacology, Dexamethasone / therapeutic use, Female, Humans, Lenalidomide / pharmacology, Lenalidomide / therapeutic use, Male, Middle Aged, Multiple Myeloma / drug therapy, Neoplasm Recurrence, Local, Retrospective Studies, Thalidomide / pharmacology, Thalidomide / therapeutic use, Treatment Outcome, Lenalidomide, Multiple myeloma, Refractory, Relapsed, Thalidomide

Relation: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA; J04262; OAK-2022-03880; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190217; https://www.sciencedirect.com/science/article/pii/S2152265019320658; T9992020442; CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, Vol.20(2) : E97-E104, 2020-02

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/190217
https://doi.org/10.1016/j.clml.2019.10.017
https://www.sciencedirect.com/science/article/pii/S2152265019320658